- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
675
Companies which are more than 50% undervalued based on analyst price target.
675 companies
Biosergen
Market Cap: SEK 110.6m
A biotech company, develops antifungal products.
BIOSGN
SEK 0.44
7D
-1.6%
1Y
-34.7%
Artelo Biosciences
Market Cap: US$11.6m
A clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States.
ARTL
US$4.35
7D
-51.9%
1Y
-42.9%
Moleculin Biotech
Market Cap: US$11.4m
A late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses.
MBRX
US$0.38
7D
-3.6%
1Y
-84.8%
Marker Therapeutics
Market Cap: US$11.2m
A clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.
MRKR
US$0.86
7D
-4.1%
1Y
-72.5%
Talphera
Market Cap: US$11.2m
A specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings.
TLPH
US$0.52
7D
-5.5%
1Y
-48.9%
Evoke Pharma
Market Cap: US$11.1m
Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.
EVOK
US$5.29
7D
0%
1Y
35.6%
Sensei Biotherapeutics
Market Cap: US$10.9m
A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.
SNSE
US$8.81
7D
5.5%
1Y
-25.3%
Lipigon Pharmaceuticals
Market Cap: SEK 103.0m
Develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.17
7D
-7.0%
1Y
-32.1%
Verici Dx
Market Cap: UK£7.9m
Together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States.
VRCI
UK£0.0053
7D
0%
1Y
-92.2%
IDL Diagnostics
Market Cap: SEK 97.7m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.43
7D
2.6%
1Y
-25.8%
IN8bio
Market Cap: US$10.1m
A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases.
INAB
US$2.18
7D
-3.5%
1Y
-78.5%
Kiora Pharmaceuticals
Market Cap: US$9.6m
A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.
KPRX
US$2.73
7D
-1.8%
1Y
-22.4%
Processa Pharmaceuticals
Market Cap: US$9.5m
A clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment.
PCSA
US$0.17
7D
-19.8%
1Y
-87.1%
AEON Biopharma
Market Cap: US$9.4m
A clinical stage biopharmaceutical company, focuses on developing botulinum toxins.
AEON
US$0.77
7D
-1.3%
1Y
-98.7%
Dogwood Therapeutics
Market Cap: US$9.4m
A development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders.
DWTX
US$5.00
7D
4.3%
1Y
8.3%
Bolt Biotherapeutics
Market Cap: US$9.3m
A clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer.
BOLT
US$4.84
7D
-8.7%
1Y
-62.8%
Biofrontera
Market Cap: US$9.3m
A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
BFRI
US$0.84
7D
-1.5%
1Y
-25.1%
Kazia Therapeutics
Market Cap: US$9.0m
Operates as an oncology-focused biotechnology company in South Korea.
KZIA
US$8.09
7D
4.7%
1Y
-60.5%
Aprea Therapeutics
Market Cap: US$8.9m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.
APRE
US$1.50
7D
-5.4%
1Y
-55.3%
Oncodesign Precision Medicine Société anonyme
Market Cap: €7.5m
A biopharmaceutical company, engages in the precision medicine business.
ALOPM
€0.43
7D
3.4%
1Y
-60.8%
CERo Therapeutics Holdings
Market Cap: US$8.7m
An immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer.
CERO
US$6.93
7D
-9.6%
1Y
-96.9%
HCW Biologics
Market Cap: US$8.7m
A clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.
HCWB
US$4.63
7D
-18.5%
1Y
-79.3%
Creative Medical Technology Holdings
Market Cap: US$8.6m
A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.
CELZ
US$3.29
7D
4.1%
1Y
-6.0%
OncoZenge
Market Cap: SEK 79.8m
A pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.
ONCOZ
SEK 6.37
7D
-5.8%
1Y
3.1%
Adial Pharmaceuticals
Market Cap: US$8.2m
A clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.
ADIL
US$0.35
7D
-10.9%
1Y
-66.0%
VYNE Therapeutics
Market Cap: US$8.1m
A clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions.
VYNE
US$0.31
7D
-5.8%
1Y
-83.9%
Brainstorm Cell Therapeutics
Market Cap: US$8.0m
A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.
BCLI
US$0.76
7D
4.4%
1Y
-81.7%
Sonoma Pharmaceuticals
Market Cap: US$7.6m
Develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
SNOA
US$4.53
7D
-0.7%
1Y
43.4%
Alzamend Neuro
Market Cap: US$7.4m
A clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.
ALZN
US$2.27
7D
-6.6%
1Y
-88.5%
AcouSort
Market Cap: SEK 65.6m
A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.
ACOU
SEK 3.15
7D
-2.2%
1Y
-79.3%
Rakovina Therapeutics
Market Cap: CA$9.6m
A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.
RKV
CA$0.43
7D
-14.0%
1Y
-52.2%
Addex Therapeutics
Market Cap: CHF 5.5m
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland.
ADXN
CHF 0.058
7D
-0.3%
1Y
-27.6%
Sprint Bioscience
Market Cap: SEK 63.7m
A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.
SPRINT
SEK 0.61
7D
7.0%
1Y
-53.7%
cbdMD
Market Cap: US$6.7m
Produces and distributes various cannabidiol (CBD) products in the United States.
YCBD
US$0.72
7D
-7.1%
1Y
-83.6%
Theracryf
Market Cap: UK£4.9m
A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders.
TCF
UK£0.0024
7D
-2.1%
1Y
-66.4%
Acurx Pharmaceuticals
Market Cap: US$6.6m
A clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States.
ACXP
US$3.86
7D
-19.1%
1Y
-90.9%